Stockreport

Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules

Palisade Bio, Inc.  (PALI) 
PDF Carlsbad, CA, May 02, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company focused on developing and advancing novel therapeutics fo [Read more]